Other

Tuberculosis complicating hepatitis C therapy with pegylated interferon and ribavirin: new infection in a high tuberculosis incidence area

Published in: Southern African Journal of Infectious Diseases
Volume 29 , issue 3, pages: 118–119

DOI: 10.1080/23120053.2014.11441583

Author(s): T K RoestoffDepartment of Gastroenterology, Charlotte Maxeke Johannesburg Academic Hospital, , T BurgerDepartment of Gastroenterology, Charlotte Maxeke Johannesburg Academic Hospital, , H SmithDepartment of Gastroenterology, Charlotte Maxeke Johannesburg Academic Hospital, , A D MahomedDepartment of Gastroenterology, Charlotte Maxeke Johannesburg Academic Hospital, ,

Keywords: hepatitis C, tuberculosis, pegylated interferon, ribavarin therapy,

Download full text Get new issue alerts

Abstract

« Vancomycin versus teicoplanin in the treatment of serious Gram-positive infections: what do the minimum inhibitory concentration data tell us?

Preventive therapy for children following contact with a tuberculosis source case: cause for debate in a high-burden setting? »

Other

Tuberculosis complicating hepatitis C therapy with pegylated interferon and ribavirin: new infection in a high tuberculosis incidence area

Abstract

Get new issue alerts for Southern African Journal of Infectious Diseases

Latest news

Latest articles